β Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart Failure

NCT02786654 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 179810

Last updated 2019-06-18

No results posted yet for this study

Summary

The aim of the study is to investigate the association between the use of β blockers and mortality among hospital survivors of acute myocardial infarction without heart failure.

Conditions

  • Acute Myocardial Infarction

Sponsors & Collaborators

  • University of Leeds

    lead OTHER

Principal Investigators

  • Chris P Gale, FRCP · University of Leeds

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02786654 on ClinicalTrials.gov